_id

695fb5adc2e91020a7bd41de

Ticker

0H8T.LSE

Name

Aclaris Therapeutics, Inc.

Exchange

LSE

Address

701 Lee Road, Wayne, PA, United States, 19087

Country

UK

Sector

Industry

Currency

USD

Website

https://www.aclaristx.com

Description

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. Its Contract Research segment provides laboratory services. The company also develops ATI-1777, a soft JAK 1/3 inhibitor in Phase 2b trial for the treatment of atopic dermatitis and other dermatologic conditions; Bosakitug (ATI-045), an anti-TSLP monoclonal antibody in Phase 2a trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease; ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor in Phase 2a trial for the treatment for T cell-mediated autoimmune diseases; Zunsemetinib (ATI-450), a mitogen-activated protein kinase-activated protein kinase 2 inhibitor under Phase 1b/2 trials for the treatment of metastatic breast cancer and pancreatic ductal adenocarcinoma; and ATI-052, a humanized anti-TSLP and anti-IL4R bispecific antibody in preclinical stage to treat various atopic, immunologic, and respiratory diseases, as well as an ITK selective inhibitor candidate for the treatment of autoimmune diseases. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Last Close

2.7

Volume

10000

Current Price

2.6201

Last Updated

2026-01-08T13:48:29.109Z

Ipo Date

-

Market Cap

7755190400

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

3299000

Cost Of Revenue

538000

Gross Profit

2761000

Operating Expenses

19910000

Operating Income

-17149000

Interest Expense

-

Pretax Income

-14614000

Net Income

-14614000

Eps

-0.11918187992428045

Dividends Per Share

-

Shares Outstanding

40936200

Income Tax Expense

-

EBITDA

-14404000

Operating Margin

-519.8241891482267

Total Other Income Expense Net

2535000

Cash

25256000

Short Term Investments

70656000

Receivables

4680000

Inventories

-

Total Current Assets

100592000

Property Plant Equipment

3239000

Total Assets

175534000

Payables

9187000

Short Term Debt

533000

Long Term Debt

-

Total Liabilities

55434000

Equity

120100000

Bs_currency_symbol

-

Depreciation

210000

Change In Working Capital

612000

Cash From Operations

-10932000

Capital Expenditures

23000

Cash From Investing

13830000

Cash From Financing

-3044000

Net Change In Cash

-146000

Cf_currency_symbol

-

PE

-

PB

2.6750612552131554

ROE

-12.16819317235637

ROA

-8.325452618865862

FCF

-10955000

Fcf Percent

-3.320703243407093

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

4.5

Growth Investing Score

3

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

3299000

Quarters > 0 > income Statement > cost Of Revenue

538000

Quarters > 0 > income Statement > gross Profit

2761000

Quarters > 0 > income Statement > operating Expenses

19910000

Quarters > 0 > income Statement > operating Income

-17149000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-14614000

Quarters > 0 > income Statement > net Income

-14614000

Quarters > 0 > income Statement > eps

-0.11918187992428045

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

122619311

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-14404000

Quarters > 0 > income Statement > operating Margin

-519.8241891482267

Quarters > 0 > income Statement > total Other Income Expense Net

2535000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

25256000

Quarters > 0 > balance Sheet > short Term Investments

70656000

Quarters > 0 > balance Sheet > receivables

4680000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

100592000

Quarters > 0 > balance Sheet > property Plant Equipment

3239000

Quarters > 0 > balance Sheet > total Assets

175534000

Quarters > 0 > balance Sheet > payables

9187000

Quarters > 0 > balance Sheet > short Term Debt

533000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

55434000

Quarters > 0 > balance Sheet > equity

120100000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

-14614000

Quarters > 0 > cash Flow > depreciation

210000

Quarters > 0 > cash Flow > change In Working Capital

612000

Quarters > 0 > cash Flow > cash From Operations

-10932000

Quarters > 0 > cash Flow > capital Expenditures

23000

Quarters > 0 > cash Flow > cash From Investing

13830000

Quarters > 0 > cash Flow > cash From Financing

-3044000

Quarters > 0 > cash Flow > net Change In Cash

-146000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

-0.11918187992428045

Quarters > 0 > ratios > PB

2.6750612552131554

Quarters > 0 > ratios > ROE

-12.16819317235637

Quarters > 0 > ratios > ROA

-8.325452618865862

Quarters > 0 > ratios > FCF

-10955000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-3.320703243407093

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

1777000

Quarters > 1 > income Statement > cost Of Revenue

1850000

Quarters > 1 > income Statement > gross Profit

-73000

Quarters > 1 > income Statement > operating Expenses

16835000

Quarters > 1 > income Statement > operating Income

-16908000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-15429000

Quarters > 1 > income Statement > net Income

-15429000

Quarters > 1 > income Statement > eps

-0.1258678274254436

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

122580967

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-15215000

Quarters > 1 > income Statement > operating Margin

-951.4912774338774

Quarters > 1 > income Statement > total Other Income Expense Net

1479000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

25402000

Quarters > 1 > balance Sheet > short Term Investments

74404000

Quarters > 1 > balance Sheet > receivables

194000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

104202000

Quarters > 1 > balance Sheet > property Plant Equipment

3437000

Quarters > 1 > balance Sheet > total Assets

189147000

Quarters > 1 > balance Sheet > payables

8797000

Quarters > 1 > balance Sheet > short Term Debt

515000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

57408000

Quarters > 1 > balance Sheet > equity

131739000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

-15429000

Quarters > 1 > cash Flow > depreciation

214000

Quarters > 1 > cash Flow > change In Working Capital

759000

Quarters > 1 > cash Flow > cash From Operations

-9993000

Quarters > 1 > cash Flow > capital Expenditures

21000

Quarters > 1 > cash Flow > cash From Investing

5047000

Quarters > 1 > cash Flow > cash From Financing

-9000

Quarters > 1 > cash Flow > net Change In Cash

-4955000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.1258678274254436

Quarters > 1 > ratios > PB

2.4379598420870052

Quarters > 1 > ratios > ROE

-11.711793774053241

Quarters > 1 > ratios > ROA

-8.157147615346794

Quarters > 1 > ratios > FCF

-10014000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-5.635340461451885

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

1455000

Quarters > 2 > income Statement > cost Of Revenue

13100000

Quarters > 2 > income Statement > gross Profit

-11645000

Quarters > 2 > income Statement > operating Expenses

6439000

Quarters > 2 > income Statement > operating Income

-18084000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-15085000

Quarters > 2 > income Statement > net Income

-15085000

Quarters > 2 > income Statement > eps

-0.12325322864835134

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

122390303

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-17756000

Quarters > 2 > income Statement > operating Margin

-1242.8865979381444

Quarters > 2 > income Statement > total Other Income Expense Net

2999000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

30357000

Quarters > 2 > balance Sheet > short Term Investments

74957000

Quarters > 2 > balance Sheet > receivables

250000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

108790000

Quarters > 2 > balance Sheet > property Plant Equipment

3649000

Quarters > 2 > balance Sheet > total Assets

198094000

Quarters > 2 > balance Sheet > payables

6354000

Quarters > 2 > balance Sheet > short Term Debt

498000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

54028000

Quarters > 2 > balance Sheet > equity

144066000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

-15085000

Quarters > 2 > cash Flow > depreciation

128000

Quarters > 2 > cash Flow > change In Working Capital

-2766000

Quarters > 2 > cash Flow > cash From Operations

-13057000

Quarters > 2 > cash Flow > capital Expenditures

43000

Quarters > 2 > cash Flow > cash From Investing

19119000

Quarters > 2 > cash Flow > cash From Financing

-275000

Quarters > 2 > cash Flow > net Change In Cash

5787000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.12325322864835134

Quarters > 2 > ratios > PB

2.225888362905196

Quarters > 2 > ratios > ROE

-10.470895284105895

Quarters > 2 > ratios > ROA

-7.615071632659243

Quarters > 2 > ratios > FCF

-13100000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-9.003436426116838

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

9211000

Quarters > 3 > income Statement > cost Of Revenue

9301000

Quarters > 3 > income Statement > gross Profit

-90000

Quarters > 3 > income Statement > operating Expenses

13980000

Quarters > 3 > income Statement > operating Income

-14070000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-96552000

Quarters > 3 > income Statement > net Income

-96552000

Quarters > 3 > income Statement > eps

-1.0130761445624152

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

95305768

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-96409000

Quarters > 3 > income Statement > operating Margin

-152.7521441754424

Quarters > 3 > income Statement > total Other Income Expense Net

-82482000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

24570000

Quarters > 3 > balance Sheet > short Term Investments

89024000

Quarters > 3 > balance Sheet > receivables

318000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

125951000

Quarters > 3 > balance Sheet > property Plant Equipment

3850000

Quarters > 3 > balance Sheet > total Assets

220327000

Quarters > 3 > balance Sheet > payables

4690000

Quarters > 3 > balance Sheet > short Term Debt

481000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

64773000

Quarters > 3 > balance Sheet > equity

155554000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

-96552000

Quarters > 3 > cash Flow > depreciation

143000

Quarters > 3 > cash Flow > change In Working Capital

-994000

Quarters > 3 > cash Flow > cash From Operations

-8938000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-88723000

Quarters > 3 > cash Flow > cash From Financing

74580000

Quarters > 3 > cash Flow > net Change In Cash

-23081000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-1.0130761445624152

Quarters > 3 > ratios > PB

1.605298756295563

Quarters > 3 > ratios > ROE

-62.069763554778405

Quarters > 3 > ratios > ROA

-43.822137096225156

Quarters > 3 > ratios > FCF

-8938000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.9703615242644664

Quarters > 3 > health Score

35

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

18720000

Annuals > 0 > income Statement > cost Of Revenue

15258000

Annuals > 0 > income Statement > gross Profit

3462000

Annuals > 0 > income Statement > operating Expenses

53289000

Annuals > 0 > income Statement > operating Income

-49827000

Annuals > 0 > income Statement > interest Expense

-

Annuals > 0 > income Statement > pretax Income

-132065000

Annuals > 0 > income Statement > net Income

-132065000

Annuals > 0 > income Statement > eps

-1.7085471928187328

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

77296665

Annuals > 0 > income Statement > income Tax Expense

-

Annuals > 0 > income Statement > EBITDA

-131258000

Annuals > 0 > income Statement > operating Margin

-266.1698717948718

Annuals > 0 > income Statement > total Other Income Expense Net

-82238000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

24570000

Annuals > 0 > balance Sheet > short Term Investments

89024000

Annuals > 0 > balance Sheet > receivables

318000

Annuals > 0 > balance Sheet > inventories

-

Annuals > 0 > balance Sheet > total Current Assets

125951000

Annuals > 0 > balance Sheet > property Plant Equipment

3850000

Annuals > 0 > balance Sheet > total Assets

220327000

Annuals > 0 > balance Sheet > payables

4690000

Annuals > 0 > balance Sheet > short Term Debt

962000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

64773000

Annuals > 0 > balance Sheet > equity

155554000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

-132065000

Annuals > 0 > cash Flow > depreciation

807000

Annuals > 0 > cash Flow > change In Working Capital

10922000

Annuals > 0 > cash Flow > cash From Operations

-20075000

Annuals > 0 > cash Flow > capital Expenditures

121000

Annuals > 0 > cash Flow > cash From Investing

-69769000

Annuals > 0 > cash Flow > cash From Financing

74536000

Annuals > 0 > cash Flow > net Change In Cash

-15308000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

-1.7085471928187328

Annuals > 0 > ratios > PB

1.301959396521465

Annuals > 0 > ratios > ROE

-84.89977756920426

Annuals > 0 > ratios > ROA

-59.94045214612825

Annuals > 0 > ratios > FCF

-20196000

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-1.0788461538461538

Annuals > 0 > health Score

35

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

31249000

Annuals > 1 > income Statement > cost Of Revenue

116465000

Annuals > 1 > income Statement > gross Profit

-85216000

Annuals > 1 > income Statement > operating Expenses

12141000

Annuals > 1 > income Statement > operating Income

-97357000

Annuals > 1 > income Statement > interest Expense

-

Annuals > 1 > income Statement > pretax Income

-88848000

Annuals > 1 > income Statement > net Income

-88481000

Annuals > 1 > income Statement > eps

-1.267475308110984

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

69808855

Annuals > 1 > income Statement > income Tax Expense

-367000

Annuals > 1 > income Statement > EBITDA

-87985000

Annuals > 1 > income Statement > operating Margin

-311.55236967582965

Annuals > 1 > income Statement > total Other Income Expense Net

8509000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

39878000

Annuals > 1 > balance Sheet > short Term Investments

79228000

Annuals > 1 > balance Sheet > receivables

298000

Annuals > 1 > balance Sheet > inventories

-

Annuals > 1 > balance Sheet > total Current Assets

128856000

Annuals > 1 > balance Sheet > property Plant Equipment

5479000

Annuals > 1 > balance Sheet > total Assets

199551000

Annuals > 1 > balance Sheet > payables

8878000

Annuals > 1 > balance Sheet > short Term Debt

852000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

42372000

Annuals > 1 > balance Sheet > equity

157179000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

-88481000

Annuals > 1 > cash Flow > depreciation

863000

Annuals > 1 > cash Flow > change In Working Capital

10862000

Annuals > 1 > cash Flow > cash From Operations

-78325000

Annuals > 1 > cash Flow > capital Expenditures

1309000

Annuals > 1 > cash Flow > cash From Investing

46220000

Annuals > 1 > cash Flow > cash From Financing

26706000

Annuals > 1 > cash Flow > net Change In Cash

-5399000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-1.267475308110984

Annuals > 1 > ratios > PB

1.1636807778742708

Annuals > 1 > ratios > ROE

-56.2931434860891

Annuals > 1 > ratios > ROA

-44.34004339742722

Annuals > 1 > ratios > FCF

-79634000

Annuals > 1 > ratios > Piotroski FScore

0

Annuals > 1 > ratios > fcf Percent

-2.5483695478255304

Annuals > 1 > health Score

34

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

29752000

Annuals > 2 > income Statement > cost Of Revenue

11960000

Annuals > 2 > income Statement > gross Profit

17792000

Annuals > 2 > income Statement > operating Expenses

102946000

Annuals > 2 > income Statement > operating Income

-85154000

Annuals > 2 > income Statement > interest Expense

-

Annuals > 2 > income Statement > pretax Income

-86908000

Annuals > 2 > income Statement > net Income

-86908000

Annuals > 2 > income Statement > eps

-1.3326597759522105

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

65213944

Annuals > 2 > income Statement > income Tax Expense

-

Annuals > 2 > income Statement > EBITDA

-86111000

Annuals > 2 > income Statement > operating Margin

-286.21269158375907

Annuals > 2 > income Statement > total Other Income Expense Net

-1754000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

45277000

Annuals > 2 > balance Sheet > short Term Investments

172294000

Annuals > 2 > balance Sheet > receivables

484000

Annuals > 2 > balance Sheet > inventories

-

Annuals > 2 > balance Sheet > total Current Assets

231550000

Annuals > 2 > balance Sheet > property Plant Equipment

3779000

Annuals > 2 > balance Sheet > total Assets

257958000

Annuals > 2 > balance Sheet > payables

10351000

Annuals > 2 > balance Sheet > short Term Debt

1368000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

60337000

Annuals > 2 > balance Sheet > equity

197621000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

-86908000

Annuals > 2 > cash Flow > depreciation

797000

Annuals > 2 > cash Flow > change In Working Capital

-1195000

Annuals > 2 > cash Flow > cash From Operations

-67567000

Annuals > 2 > cash Flow > capital Expenditures

605000

Annuals > 2 > cash Flow > cash From Investing

12628000

Annuals > 2 > cash Flow > cash From Financing

72867000

Annuals > 2 > cash Flow > net Change In Cash

17928000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-1.3326597759522105

Annuals > 2 > ratios > PB

0.8646199274085243

Annuals > 2 > ratios > ROE

-43.97710769604445

Annuals > 2 > ratios > ROA

-33.690755859481

Annuals > 2 > ratios > FCF

-68172000

Annuals > 2 > ratios > Piotroski FScore

0

Annuals > 2 > ratios > fcf Percent

-2.291341758537241

Annuals > 2 > health Score

33

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

6761000

Annuals > 3 > income Statement > cost Of Revenue

4713000

Annuals > 3 > income Statement > gross Profit

2048000

Annuals > 3 > income Statement > operating Expenses

67432000

Annuals > 3 > income Statement > operating Income

-65384000

Annuals > 3 > income Statement > interest Expense

-

Annuals > 3 > income Statement > pretax Income

-90865000

Annuals > 3 > income Statement > net Income

-90865000

Annuals > 3 > income Statement > eps

-1.6016933934911264

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

56730583

Annuals > 3 > income Statement > income Tax Expense

-

Annuals > 3 > income Statement > EBITDA

-89942000

Annuals > 3 > income Statement > operating Margin

-967.0758763496524

Annuals > 3 > income Statement > total Other Income Expense Net

-25481000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

27349000

Annuals > 3 > balance Sheet > short Term Investments

164065000

Annuals > 3 > balance Sheet > receivables

623000

Annuals > 3 > balance Sheet > inventories

-

Annuals > 3 > balance Sheet > total Current Assets

205032000

Annuals > 3 > balance Sheet > property Plant Equipment

4772000

Annuals > 3 > balance Sheet > total Assets

251211000

Annuals > 3 > balance Sheet > payables

9985000

Annuals > 3 > balance Sheet > short Term Debt

1415000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

53870000

Annuals > 3 > balance Sheet > equity

197341000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-90865000

Annuals > 3 > cash Flow > depreciation

923000

Annuals > 3 > cash Flow > change In Working Capital

-1343000

Annuals > 3 > cash Flow > cash From Operations

-52134000

Annuals > 3 > cash Flow > capital Expenditures

308000

Annuals > 3 > cash Flow > cash From Investing

-167632000

Annuals > 3 > cash Flow > cash From Financing

225052000

Annuals > 3 > cash Flow > net Change In Cash

5286000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-1.6016933934911264

Annuals > 3 > ratios > PB

0.7532129690145484

Annuals > 3 > ratios > ROE

-46.04466380529135

Annuals > 3 > ratios > ROA

-36.17078869953943

Annuals > 3 > ratios > FCF

-52442000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-7.7565448898091995

Annuals > 3 > health Score

33

Valuation > metrics > PE

-0.11918187992428045

Valuation > metrics > PB

2.6750612552131554

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-12.16819317235637

Profitability > metrics > ROA

-14.52799427389852

Profitability > metrics > Net Margin

-4.429827220369809

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.4615653621981682

Risk > metrics > Interest Coverage

-81.66190476190476

Risk > final Score

-267

Risk > verdict

High

Liquidity > metrics > Current Ratio

10.348971193415638

Liquidity > metrics > Quick Ratio

10.348971193415638

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-256

Prev Risks > 1

33

Prev Risks > 2

-334

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:26.740Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-26

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

-0.14

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-